<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:department>School of Medical Sciences</gtr:department><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1DA46FCE-C89A-48D8-8EE7-F931790E19D5"><gtr:id>1DA46FCE-C89A-48D8-8EE7-F931790E19D5</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Langston</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/26310B71-5108-4FEA-8F7D-AA05CA2A0FA3"><gtr:id>26310B71-5108-4FEA-8F7D-AA05CA2A0FA3</gtr:id><gtr:firstName>Marion</gtr:firstName><gtr:otherNames>K</gtr:otherNames><gtr:surname>Campbell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/94186691-E7FD-4DA9-928F-ED26535A07BB"><gtr:id>94186691-E7FD-4DA9-928F-ED26535A07BB</gtr:id><gtr:firstName>Theresa Mary</gtr:firstName><gtr:surname>Marteau</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8E0EE1D1-C8F1-4471-9BC7-802B85DE9E7D"><gtr:id>8E0EE1D1-C8F1-4471-9BC7-802B85DE9E7D</gtr:id><gtr:firstName>Marilyn</gtr:firstName><gtr:surname>McCallum</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5D6DA59F-7145-4553-BAD0-E5CE3771F4F5"><gtr:id>5D6DA59F-7145-4553-BAD0-E5CE3771F4F5</gtr:id><gtr:firstName>M</gtr:firstName><gtr:surname>Johnston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1E9ED8CE-0D66-4BCB-8CC9-91B5A698F8BA"><gtr:id>1E9ED8CE-0D66-4BCB-8CC9-91B5A698F8BA</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:surname>Ralston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C17736A4-8483-4B79-B340-91EBC21B08EE"><gtr:id>C17736A4-8483-4B79-B340-91EBC21B08EE</gtr:id><gtr:firstName>Jilllian</gtr:firstName><gtr:otherNames>Joy</gtr:otherNames><gtr:surname>Francis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400634"><gtr:id>C977B8EC-64B3-495D-8402-2814B12F5784</gtr:id><gtr:title>Acceptability of genetic testing and preventative treatment in Paget's disease: psychological and clinical predictors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400634</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>264676</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Patient support group presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>54E7820B-00A1-405C-AA2E-04308163BC7A</gtr:id><gtr:impact>Presentation at an Annual General Meeting, which generated interst and questions

Membership of the association understood the requirement for the clinical trial that resulkted from this research, and agreed to provide information about the clinical trial to members.</gtr:impact><gtr:outcomeId>XeiwU1X68pq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Trials</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>92855ACC-50D3-404F-ADD8-8111A7A354FC</gtr:id><gtr:outcomeId>jmkckygzchZ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Trials</gtr:description><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>260DC907-48DC-49AF-BD00-30265969F0F0</gtr:id><gtr:outcomeId>jmkckygzchZ1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DBC833BA-04B9-4B58-8B6E-0740E485C902</gtr:id><gtr:title>Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available.</gtr:title><gtr:parentPublicationTitle>BMC health services research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/201eab7074e2d7637267ee601f71d550"><gtr:id>201eab7074e2d7637267ee601f71d550</gtr:id><gtr:otherNames>Langston AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1472-6963</gtr:issn><gtr:outcomeId>dmZMGfaAbX4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27F996AE-9746-4157-A46C-DAEBA2B397D0</gtr:id><gtr:title>Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?</gtr:title><gtr:parentPublicationTitle>BMC health services research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/201eab7074e2d7637267ee601f71d550"><gtr:id>201eab7074e2d7637267ee601f71d550</gtr:id><gtr:otherNames>Langston AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1472-6963</gtr:issn><gtr:outcomeId>skK4VLj3oCq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FD67DF9-FEBC-4F7A-9DA3-88CEC826A2FB</gtr:id><gtr:title>What is an adequate sample size? Operationalising data saturation for theory-based interview studies.</gtr:title><gtr:parentPublicationTitle>Psychology &amp; health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4134f0042aad5afb4db8cefe55c9c2d8"><gtr:id>4134f0042aad5afb4db8cefe55c9c2d8</gtr:id><gtr:otherNames>Francis JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0887-0446</gtr:issn><gtr:outcomeId>f34Pvf1gXUF</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400634</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>E8160779-C41E-46F6-B795-59C27D6B2E2B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.3  Influences and impact</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>